Selected research
Industry Growth & Trends
Global Chronic Disease Data Management Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Chronic Disease Data Management Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Chronic Disease Data Management Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Chronic Disease Data Management Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chronic Disease Data Management Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Chronic Disease Data Management Software market include Vistel, Tianjin Jiuan Medical Electronics, Human Metabolomics Institute, Inc., ScienceSoft, Qure4u, Cognizant, Infosys Limited, Pegasystems Inc. and Siemens Healthcare Private Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Chronic Disease Data Management Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chronic Disease Data Management Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Disease Data Management Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Disease Data Management Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Chronic Disease Data Management Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chronic Disease Data Management Software Market by Company
Vistel
Tianjin Jiuan Medical Electronics
Human Metabolomics Institute, Inc.
ScienceSoft
Qure4u
Cognizant
Infosys Limited
Pegasystems Inc.
Siemens Healthcare Private Limited
MINES & Associates Inc
Allscripts
HealthSmart
Philips
EXL Healthcare
EquityNet
Cabot Solutions Inc.
VITECH
Empeek
Arkenea
Chronic Disease Data Management Software Segment by Type
Cloud-based
Local Deployment
Chronic Disease Data Management Software Segment by Application
Arthropathy
Cardiovascular Diseases
Cancer
Diabetic
Others
Chronic Disease Data Management Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Disease Data Management Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Disease Data Management Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Disease Data Management Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Chronic Disease Data Management Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- Local Deployment
Applications
- Arthropathy
- Cardiovascular Diseases
- Cancer
- Diabetic
- Others
Companies covered
- Vistel
- Tianjin Jiuan Medical Electronics
- Human Metabolomics Institute, Inc.
- ScienceSoft
- Qure4u
- Cognizant
- Infosys Limited
- Pegasystems Inc.
- Siemens Healthcare Private Limited
- MINES & Associates Inc
- Allscripts
- HealthSmart
- Philips
- EXL Healthcare
- EquityNet
- Cabot Solutions Inc.
- VITECH
- Empeek
- Arkenea
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Chronic Disease Data Management Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Chronic Disease Data Management Software Market Size by Region (2021-2032)
- 1.4.1 Global Chronic Disease Data Management Software Market Size by Region (2021-2026)
- 1.4.2 Global Chronic Disease Data Management Software Market Size by Region (2027-2032)
- 1.5 Key Regions Chronic Disease Data Management Software Market Size (2021-2032)
- 1.5.1 North America Chronic Disease Data Management Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Chronic Disease Data Management Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Chronic Disease Data Management Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Chronic Disease Data Management Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Chronic Disease Data Management Software Market Size Growth Rate (2021-2032)
2 Chronic Disease Data Management Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Cloud-based
- 2.1.2 Local Deployment
- 2.2 Global Chronic Disease Data Management Software Market Size by Type
- 2.2.1 Global Chronic Disease Data Management Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Chronic Disease Data Management Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Chronic Disease Data Management Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Chronic Disease Data Management Software Market Size by Regions
- 2.3.1 North America Chronic Disease Data Management Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Chronic Disease Data Management Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Chronic Disease Data Management Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Chronic Disease Data Management Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Chronic Disease Data Management Software Market Size Breakdown by Type (2021-2026)
3 Chronic Disease Data Management Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Arthropathy
- 3.1.2 Cardiovascular Diseases
- 3.1.3 Cancer
- 3.1.4 Diabetic
- 3.1.5 Others
- 3.2 Global Chronic Disease Data Management Software Market Size by Application
- 3.2.1 Global Chronic Disease Data Management Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Chronic Disease Data Management Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Chronic Disease Data Management Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Chronic Disease Data Management Software Market Size by Regions
- 3.3.1 North America Chronic Disease Data Management Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Chronic Disease Data Management Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Chronic Disease Data Management Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Chronic Disease Data Management Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Chronic Disease Data Management Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Chronic Disease Data Management Software Industry Trends
- 4.2 Chronic Disease Data Management Software Industry Drivers
- 4.3 Chronic Disease Data Management Software Industry Opportunities and Challenges
- 4.4 Chronic Disease Data Management Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Chronic Disease Data Management Software Revenue (2021-2026)
- 5.2 Global Chronic Disease Data Management Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Chronic Disease Data Management Software Key Company Headquarters & Area Served
- 5.4 Global Chronic Disease Data Management Software Company, Product Type & Application
- 5.5 Global Chronic Disease Data Management Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Chronic Disease Data Management Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Chronic Disease Data Management Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Chronic Disease Data Management Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Vistel
- 6.1.1 Vistel Company Information
- 6.1.2 Vistel Business Overview
- 6.1.3 Vistel Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Vistel Chronic Disease Data Management Software Product Portfolio
- 6.1.5 Vistel Recent Developments
- 6.2 Tianjin Jiuan Medical Electronics
- 6.2.1 Tianjin Jiuan Medical Electronics Company Information
- 6.2.2 Tianjin Jiuan Medical Electronics Business Overview
- 6.2.3 Tianjin Jiuan Medical Electronics Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Tianjin Jiuan Medical Electronics Chronic Disease Data Management Software Product Portfolio
- 6.2.5 Tianjin Jiuan Medical Electronics Recent Developments
- 6.3 Human Metabolomics Institute, Inc.
- 6.3.1 Human Metabolomics Institute, Inc. Company Information
- 6.3.2 Human Metabolomics Institute, Inc. Business Overview
- 6.3.3 Human Metabolomics Institute, Inc. Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Human Metabolomics Institute, Inc. Chronic Disease Data Management Software Product Portfolio
- 6.3.5 Human Metabolomics Institute, Inc. Recent Developments
- 6.4 ScienceSoft
- 6.4.1 ScienceSoft Company Information
- 6.4.2 ScienceSoft Business Overview
- 6.4.3 ScienceSoft Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ScienceSoft Chronic Disease Data Management Software Product Portfolio
- 6.4.5 ScienceSoft Recent Developments
- 6.5 Qure4u
- 6.5.1 Qure4u Company Information
- 6.5.2 Qure4u Business Overview
- 6.5.3 Qure4u Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Qure4u Chronic Disease Data Management Software Product Portfolio
- 6.5.5 Qure4u Recent Developments
- 6.6 Cognizant
- 6.6.1 Cognizant Company Information
- 6.6.2 Cognizant Business Overview
- 6.6.3 Cognizant Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Cognizant Chronic Disease Data Management Software Product Portfolio
- 6.6.5 Cognizant Recent Developments
- 6.7 Infosys Limited
- 6.7.1 Infosys Limited Company Information
- 6.7.2 Infosys Limited Business Overview
- 6.7.3 Infosys Limited Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Infosys Limited Chronic Disease Data Management Software Product Portfolio
- 6.7.5 Infosys Limited Recent Developments
- 6.8 Pegasystems Inc.
- 6.8.1 Pegasystems Inc. Company Information
- 6.8.2 Pegasystems Inc. Business Overview
- 6.8.3 Pegasystems Inc. Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Pegasystems Inc. Chronic Disease Data Management Software Product Portfolio
- 6.8.5 Pegasystems Inc. Recent Developments
- 6.9 Siemens Healthcare Private Limited
- 6.9.1 Siemens Healthcare Private Limited Company Information
- 6.9.2 Siemens Healthcare Private Limited Business Overview
- 6.9.3 Siemens Healthcare Private Limited Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Siemens Healthcare Private Limited Chronic Disease Data Management Software Product Portfolio
- 6.9.5 Siemens Healthcare Private Limited Recent Developments
- 6.10 MINES & Associates Inc
- 6.10.1 MINES & Associates Inc Company Information
- 6.10.2 MINES & Associates Inc Business Overview
- 6.10.3 MINES & Associates Inc Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 MINES & Associates Inc Chronic Disease Data Management Software Product Portfolio
- 6.10.5 MINES & Associates Inc Recent Developments
- 6.11 Allscripts
- 6.11.1 Allscripts Company Information
- 6.11.2 Allscripts Business Overview
- 6.11.3 Allscripts Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Allscripts Chronic Disease Data Management Software Product Portfolio
- 6.11.5 Allscripts Recent Developments
- 6.12 HealthSmart
- 6.12.1 HealthSmart Company Information
- 6.12.2 HealthSmart Business Overview
- 6.12.3 HealthSmart Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 HealthSmart Chronic Disease Data Management Software Product Portfolio
- 6.12.5 HealthSmart Recent Developments
- 6.13 Philips
- 6.13.1 Philips Company Information
- 6.13.2 Philips Business Overview
- 6.13.3 Philips Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Philips Chronic Disease Data Management Software Product Portfolio
- 6.13.5 Philips Recent Developments
- 6.14 EXL Healthcare
- 6.14.1 EXL Healthcare Company Information
- 6.14.2 EXL Healthcare Business Overview
- 6.14.3 EXL Healthcare Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 EXL Healthcare Chronic Disease Data Management Software Product Portfolio
- 6.14.5 EXL Healthcare Recent Developments
- 6.15 EquityNet
- 6.15.1 EquityNet Company Information
- 6.15.2 EquityNet Business Overview
- 6.15.3 EquityNet Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 EquityNet Chronic Disease Data Management Software Product Portfolio
- 6.15.5 EquityNet Recent Developments
- 6.16 Cabot Solutions Inc.
- 6.16.1 Cabot Solutions Inc. Company Information
- 6.16.2 Cabot Solutions Inc. Business Overview
- 6.16.3 Cabot Solutions Inc. Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Cabot Solutions Inc. Chronic Disease Data Management Software Product Portfolio
- 6.16.5 Cabot Solutions Inc. Recent Developments
- 6.17 VITECH
- 6.17.1 VITECH Company Information
- 6.17.2 VITECH Business Overview
- 6.17.3 VITECH Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 VITECH Chronic Disease Data Management Software Product Portfolio
- 6.17.5 VITECH Recent Developments
- 6.18 Empeek
- 6.18.1 Empeek Company Information
- 6.18.2 Empeek Business Overview
- 6.18.3 Empeek Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Empeek Chronic Disease Data Management Software Product Portfolio
- 6.18.5 Empeek Recent Developments
- 6.19 Arkenea
- 6.19.1 Arkenea Company Information
- 6.19.2 Arkenea Business Overview
- 6.19.3 Arkenea Chronic Disease Data Management Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Arkenea Chronic Disease Data Management Software Product Portfolio
- 6.19.5 Arkenea Recent Developments
7 North America
- 7.1 North America Chronic Disease Data Management Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 7.3 North America Chronic Disease Data Management Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Chronic Disease Data Management Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 8.3 Europe Chronic Disease Data Management Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Disease Data Management Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Chronic Disease Data Management Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Chronic Disease Data Management Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 10.3 South America Chronic Disease Data Management Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Disease Data Management Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Chronic Disease Data Management Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst